UBI Pharma Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares UBI Pharma Inc with three other
companies in this sector in Taiwan:
Johnson Chemical Pharmaceutical Works Co Ltd
sales of 411.91 million Taiwanese Dollars [US$13.51 million]
Genovate Biotechnology Co., Limited
(455.80 million Taiwanese Dollars [US$14.95 million]
of which 94%
was Medicine Manufacturing), and
Sagittarius Life Science Corp.
(411.41 million Taiwanese Dollars [US$13.50 million]
of which 96%
was Non-toxic sector).